LATS1 and neoplasm: Other tumor suppressor genes, often altered in MPM patients, are LATS1/2 [11,143], negative regulators of the Hippo-YAP pathway, whose deletion improved tumor immunogenicity together with an enhanced anti-tumor immune response [144].